The recent FDA approval of Donanemab has sparked celebration within the Alzheimer's research community, offering significant hope by slowing cognitive…
Alzheimer's disease is a degenerative brain disorder that impacts millions globally. While the exact cause of the disease is still…
In the ongoing pursuit of understanding Alzheimer's disease (AD), scientists are taking a closer look at the genetic landscape. Their…
Alzheimer’s disease (AD) is a complex neurodegenerative disease that occurs due to an accumulation of amyloid plaques and neurofibrillary tangles…